Intrinsic Value of S&P & Nasdaq Contact Us

Heska Corporation HSKA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$159.50
+32.9%

Financial Health Score — HSKA

Heska Corporation (HSKA) has an overall financial health rating of B+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-06-12.

B+
Overall Rating
2023-06-12

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-06-12 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-06-09 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-06-08 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-06-07 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-06-06 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-06-05 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-06-02 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-06-01 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-05-31 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-05-30 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-05-26 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-05-25 B+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message